2022 annual financial data
Lexaria Bioscience 2022 Financial results
Direct answer
Revenue was 255,397 USD.
Operating income was -6,619,039 USD and net income was -7,269,324 USD.
Operating cash flow was -4,879,339 USD.
Get free Lexaria Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 255,397 USD
- Operating income
- -6,619,039 USD
- Net income
- -7,269,324 USD
- Operating cash flow
- -4,879,339 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Lexaria Bioscience financial years